April 17, 2014 3:04 PM ET

Pharmaceuticals

Company Overview of Tobira Therapeutics, Inc.

Executive Profile

Andrew Hindman M.B.A

Senior Vice President of Corporate Development, Nodality, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.

----

Background

Mr. Andrew Hindman served as the Chief Executive Officer and President of Tobira Therapeutics, Inc. since April 2011. Mr. Hindman served as Senior Vice President of Corporate Development at Nodality, Inc. since joining in May 2010. He served as Vice President of Corporate Development at Onyx Pharmaceuticals since August 2008. During his tenure, he helped build a world-class corporate development capability, executed strategic partnerships and led the acquisition of Proteolix. ...

Corporate Headquarters

198 Route 9 North
Manalapan, New Jersey 07726

United States

Phone: 732-863-5980
Fax: --

Board Members Memberships

Former Chief Executive Officer, President and Director

Education

MBA
Columbia Business School
MBA
Columbia University
BA
Wesleyan University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tobira Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.